GLEIBERMAN ANATOLI,BURDELYA LYUDMILA,GUDKOV ANDREI
申请号：
CL2013002001
公开号：
CL2013002001A1
申请日:
2013.07.08
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.USO DE UN AGONISTA DEL RECEPTOR TIPO TOLL PARA EL TRATAMIENTO DEL CANCER.
